<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1717">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04838119</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00071985</org_study_id>
    <nct_id>NCT04838119</nct_id>
  </id_info>
  <brief_title>Preop COVID Testing Patterns</brief_title>
  <official_title>Preoperative COVID Testing as a Predictor of Community Disease Burden</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is an investigation of preoperative asymptomatic COVID screening nationwide. The&#xD;
      hypothesis is that because these tests are performed without reference to pretest probability&#xD;
      of COVID-19 disease, unlike tests based on symptoms or close contact with infected&#xD;
      individuals, they may represent a more unbiased sample of the local population prevalence of&#xD;
      asymptomatic COVID disease burden.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study will gather publicly reported, aggregated statistics on positive COVID tests over time&#xD;
      and across geographically diverse parts of the United States, summarized weekly, from the&#xD;
      onset of the pandemic in Spring 2020 to the present time. Study will also gather&#xD;
      contemporaneous data on weekly community COVID cases diagnosed, local positive test&#xD;
      percentage, hospital admissions and ICU admissions for COVID-19, and deaths from COVID 19.&#xD;
      Similar data will be obtained from a coalition of approximately 20 academic medical centers&#xD;
      from around the United States, with Wake Forest School of Medicine, Department of&#xD;
      Anesthesiology serving as the coordinating center. No individual patient information will be&#xD;
      collected. Aggregated testing data, hospital disease burden, and local disease prevalence are&#xD;
      all publicly reported.&#xD;
&#xD;
      We will analyze the data as interrupted time series.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2021</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of asymptomatic preoperative COVID-19 positive testing</measure>
    <time_frame>March 2020-February 2021</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of hospitalization per geographic area</measure>
    <time_frame>March 2020-February 2021</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of death per geographic area</measure>
    <time_frame>March 2020-February 2021</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU census per geographic area</measure>
    <time_frame>March 2020-February 2021</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of asymptomatic preoperative COVID-19 positive testing per geographic area</measure>
    <time_frame>March 2020-February 2021</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300000</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Patients with a preoperative asymptomatic COVID screening test</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Publicly reported aggregate data on asymptomatic preoperative COVID tests (no individual&#xD;
        patient information)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  having preoperative asymptomatic COVID testing&#xD;
&#xD;
          -  &gt; or = 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>B S Segal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest Health Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>B S Segal, MD</last_name>
    <phone>3367168190</phone>
    <email>bsegal@wakehealth.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lynnette Harris, BSN, RN</last_name>
    <phone>3367168791</phone>
    <email>lcharris@wakehealth.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Scott Segal, MD</last_name>
      <phone>336-716-4497</phone>
    </contact>
    <contact_backup>
      <last_name>Lynnette Harris, BSN, RN</last_name>
      <phone>3367168791</phone>
    </contact_backup>
    <investigator>
      <last_name>Scott Segal, MD, MHCM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>April 7, 2021</study_first_submitted>
  <study_first_submitted_qc>April 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Testing, preoperative</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

